Learning self-supervised molecular representations for drug–drug interaction prediction
Abstract Drug–drug interactions (DDI) are a critical concern in healthcare due to their potential to cause adverse effects and compromise patient safety. Supervised machine learning models for DDI prediction need to be optimized to learn abstract, transferable features, and generalize to larger chem...
Main Authors: | Rogia Kpanou, Patrick Dallaire, Elsa Rousseau, Jacques Corbeil |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12859-024-05643-7 |
Similar Items
-
On the robustness of generalization of drug–drug interaction models
by: Rogia Kpanou, et al.
Published: (2021-10-01) -
Small molecule drug and biotech drug interaction prediction based on multi-modal representation learning
by: Dingkai Huang, et al.
Published: (2022-12-01) -
Connecting the dots: Nonlinear patterns in the presence of symbolic and nonsymbolic numerical standards
by: Roland Imhoff, et al.
Published: (2023-01-01) -
Machine Learning-Based Prediction of Drug-Drug Interactions for Histamine Antagonist Using Hybrid Chemical Features
by: Luong Huu Dang, et al.
Published: (2021-11-01) -
Phar-LSTM: a pharmacological representation-based LSTM network for drug–drug interaction extraction
by: Mingqing Huang, et al.
Published: (2023-12-01)